Cargando…
Targeted Therapy in Leukaemia, Lymphoma and Myeloma
Autor principal: | Opat, Stephen Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781269/ https://www.ncbi.nlm.nih.gov/pubmed/35055389 http://dx.doi.org/10.3390/jpm12010074 |
Ejemplares similares
-
Acute Myeloid Leukaemia: New Targets and Therapies
por: Brown, Geoffrey, et al.
Publicado: (2017) -
Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma
por: Howell, Debra A, et al.
Publicado: (2015) -
Serum angiotensin-converting enzyme in malignant lymphomas, leukaemia and multiple myeloma.
por: Rømer, F. K., et al.
Publicado: (1980) -
Molecular Mechanisms and Therapies of Myeloid Leukaemia
por: Brown, Elliott, et al.
Publicado: (2022) -
Occupational cancer in Britain: Haematopoietic malignancies: leukaemia, multiple myeloma, non-Hodgkins lymphoma
por: Brown, Terry, et al.
Publicado: (2012)